CHAPTER 1. Industry Overview of Amniotic Membrane Market
1.1. Definition and Scope
1.1.1. Definition of Amniotic Membrane
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Amniotic Membrane Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Amniotic Membrane Market By Enzyme
1.2.3. Amniotic Membrane Market By Application
1.2.4. Amniotic Membrane Market By End-Use
1.2.5. Amniotic Membrane Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Amniotic Membrane Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Amniotic Membrane Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Amniotic Membrane Market By Enzyme
4.1. Introduction
4.2. Amniotic Membrane Revenue By Enzyme
4.2.1. Amniotic Membrane Revenue (USD Billion) and Forecast, By Enzyme, 2018-2030
4.2.2. Cryopreserved Amniotic Membrane
4.2.2.1. Cryopreserved Amniotic Membrane Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Dehydrated Amniotic Membrane
4.2.3.1. Dehydrated Amniotic Membrane Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Amniotic Membrane Market By Application
5.1. Introduction
5.2. Amniotic Membrane Revenue By Application
5.2.1. Amniotic Membrane Revenue (USD Billion) and Forecast, By Application, 2018-2030
5.2.2. Surgical Wounds
5.2.2.1. Surgical Wounds Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Ophthalmology
5.2.3.1. Ophthalmology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Others
5.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Amniotic Membrane Market By End-Use
6.1. Introduction
6.2. Amniotic Membrane Revenue By End-Use
6.2.1. Amniotic Membrane Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Ambulatory Settings
6.2.3.1. Ambulatory Settings Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Specialty Clinics
6.2.4.1. Specialty Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.5. Research and Academic Institutes
6.2.5.1. Research and Academic Institutes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Amniotic Membrane Market By Country
7.1. North America Amniotic Membrane Market Overview
7.2. U.S.
7.2.1. U.S. Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
7.2.2. U.S. Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
7.2.3. U.S. Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
7.3. Canada
7.3.1. Canada Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
7.3.2. Canada Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
7.3.3. Canada Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Amniotic Membrane Market By Country
8.1. Europe Amniotic Membrane Market Overview
8.2. U.K.
8.2.1. U.K. Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
8.2.2. U.K. Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
8.2.3. U.K. Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.3. Germany
8.3.1. Germany Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
8.3.2. Germany Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
8.3.3. Germany Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.4. France
8.4.1. France Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
8.4.2. France Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
8.4.3. France Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.5. Spain
8.5.1. Spain Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
8.5.2. Spain Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
8.5.3. Spain Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
8.6.2. Rest of Europe Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
8.6.3. Rest of Europe Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Amniotic Membrane Market By Country
9.1. Asia Pacific Amniotic Membrane Market Overview
9.2. China
9.2.1. China Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.2.2. China Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.2.3. China Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3. Japan
9.3.1. Japan Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.3.2. Japan Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.3.3. Japan Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.4. India
9.4.1. India Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.4.2. India Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.4.3. India Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.5. Australia
9.5.1. Australia Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.5.2. Australia Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.5.3. Australia Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.6. South Korea
9.6.1. South Korea Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.6.2. South Korea Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.6.3. South Korea Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.7.2. Rest of Asia-Pacific Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.7.3. Rest of Asia-Pacific Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Amniotic Membrane Market By Country
10.1. Latin America Amniotic Membrane Market Overview
10.2. Brazil
10.2.1. Brazil Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
10.2.2. Brazil Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
10.2.3. Brazil Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Mexico
10.3.1. Mexico Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
10.3.2. Mexico Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
10.3.3. Mexico Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
10.4.2. Rest of Latin America Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
10.4.3. Rest of Latin America Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Amniotic Membrane Market By Country
11.1. Middle East & Africa Amniotic Membrane Market Overview
11.2. GCC
11.2.1. GCC Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
11.2.2. GCC Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
11.2.3. GCC Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. South Africa
11.3.1. South Africa Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
11.3.2. South Africa Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
11.3.3. South Africa Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
11.4.2. Rest of Middle East & Africa Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
11.4.3. Rest of Middle East & Africa Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Amniotic Membrane Market
12.1. Amniotic Membrane Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Amniotic Membrane Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Amnio Technology
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. Amnio Technology 2021 Amniotic Membrane Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Alliqua BioMedical Inc.
13.3. Applied Biologics LLC
13.4. Katena Products
13.5. Human Regenerative Technologies
13.6. DermaSciences
13.7. Organogensis, Inc.
13.8. Katena Products, Inc.
13.9. Skye Biologics, Inc.
13.10. MiMedx Group Inc.
The market size of amniotic membrane market in 2021 was accounted to be USD 3.1 Billion.
The projected CAGR of amniotic membrane market during the analysis period of 2022 to 2030 is 14.2%.
The prominent players of the global amniotic membrane market include Amnio Technology, Alliqua BioMedical Inc., Applied Biologics LLC, Human Regenerative Technologies, Amniox Medical Inc., DermaSciences, Organogensis, Inc., Katena Products, Inc., Skye Biologics, Inc., and MiMedx Group Inc.
North America held the dominating amniotic membrane during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for amniotic membrane during the analysis period of 2022 to 2030.
Growing in the target patient population, growth in the number of accident and trauma wounds, and rising awareness towards benefits offered by amniotic membrane drives the growth of global amniotic membrane market.
Based on enzyme, cryopreserved amniotic membrane segment is expected to hold the maximum share amniotic membrane market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date